第一单位：
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: longoni.mattia@hsr.it.
作者：
Mattia,Longoni [1]
;
Natali,Rodriguez Peñaranda [2]
;
Andrea,Marmiroli [3]
;
Fabian,Falkenbach [4]
;
Quynh Chi,Le [5]
;
Michele,Nicolazzini [6]
;
Calogero,Catanzaro [7]
;
Zhe,Tian [8]
;
Jordan A,Goyal [8]
;
Stefano,Puliatti [9]
;
Ottavio,De Cobelli [10]
;
Markus,Graefen [11]
;
Felix K H,Chun [12]
;
Carlotta,Palumbo [6]
;
Riccardo,Schiavina [7]
;
Fred,Saad [8]
;
Shahrokh F,Shariat [13]
;
Marco,Moschini [14]
;
Giorgio,Gandaglia [14]
;
Francesco,Montorsi [14]
;
Alberto,Briganti [14]
;
Pierre I,Karakiewicz [8]
作者单位：
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: longoni.mattia@hsr.it.
[1]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, Ospedale Policlinico e Nuovo Ospedale Civile S. Agostino Estense Modena, University of Modena and Reggio Emilia, Modena, Italy.
[2]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
[3]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
[4]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
[5]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Division of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy; Division of Urology, Department of Oncology, University of Turin, Orbassano, Italy.
[6]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, University of Bologna, St. Orsola-Malpighi Hospital, Bologna, Italy.
[7]
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
[8]
Department of Urology, Ospedale Policlinico e Nuovo Ospedale Civile S. Agostino Estense Modena, University of Modena and Reggio Emilia, Modena, Italy.
[9]
Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
[10]
Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
[11]
Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
[12]
Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Hourani Center of Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
[13]
Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
[14]
DOI
10.1016/j.urology.2025.02.051
PMID
40057122
发布时间
2025-07-24
换一批
